Kinetic analyses were performed using a Biacore T200 (GE Healthcare) at 25 °C. Amine coupling chemistry (NHS/EDC kit, GE Healthcare) was used to covalently immobilize SPINK1 and N34S mutant on a CM5 sensor chip surface (GE Healthcare). SPINK1 constructs were immobilized using a concentration of 10 μg/mL in 10 mM MES (2-(N-morpholino)ethanesulfonic acid) buffer, pH 5.5 to a density below 40 response units (RU). Ethanolamine-inactivated flow cells were used for referencing and data was collected at 10 Hz. Human cationic trypsin (MW: 26.5 kDa; GenWay Biotech, San Diego, US) was prepared as two-fold dilutions in running buffer (100 mM Tris, 150 mM NaCl, 1 mM CaCl2, 0.05% Tween20, pH 8.0 or 4.8, respectively). Trypsin was injected over the biosensor surface for 180 s followed by a dissociation time of 1000 s at a flow rate of 40 μL/min. The surfaces were regenerated after each cycle with regeneration solution (10 mM glycine/HCl, pH 2.0) for 100 s. Three independent experiments were carried out in each case. Data from six different concentrations between 1.56 and 50 nM were double referenced and fitted globally by a heterogeneous ligand model (BIAevaluation 3.1, GE Healthcare) to determine the binding parameters KD1,2, kon1,2 and koff1,2.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.